Jeff Caravella
Geen lopende functies
Vermogen: - $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Jeff Caravella
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jeff Caravella via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
PACIFIC SOFTWARE, INC. | Packaged Software | Director/Board Member | |
A.C. SIMMONDS AND SONS INC | Movies/Entertainment | Director/Board Member | |
University of Cambridge | College/University | Doctorate Degree | |
Babson College | College/University | Masters Business Admin | |
Brandeis University | College/University | Graduate Degree | |
University of Toronto | College/University | Undergraduate Degree | |
University of Western Ontario | College/University | Doctorate Degree | |
University of Richmond | College/University | Undergraduate Degree | |
CardioGenics, Inc.
CardioGenics, Inc. BiotechnologyHealth Technology CardioGenics, Inc. manufactures biotechnology and medical devices. It develops in-vitro-diagnostics cardiac testing products. The company was founded in 1997 and is headquartered in Mississauga, Canada. | Biotechnology | Director/Board Member | |
AVIVAGEN INC. | Pharmaceuticals: Major | Director/Board Member | |
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
CANADIAN OIL RECOVERY & REMEDIATION ENTERPRISES LTD. | Environmental Services | Director/Board Member | |
Toronto Innovation Acceleration Partners
Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CARDIOGENICS HOLDINGS INC | Medical Specialties | Director/Board Member | |
Axcelon Biopolymers Corp.
Axcelon Biopolymers Corp. Electronic Equipment/InstrumentsElectronic Technology Axcelon Biopolymers Corp. provides medical devices for human health applications. It provides devices to those companies which uses nanotechnology to biodegradable polymer design and applications. Its technology includes stent coating, ophthalmology, drug delivery and regenerative medicine. The company is headquartered in Toronto, Canada | Electronic Equipment/Instruments | Chief Executive Officer | |
Mentra Nova Enterprises, Inc. | President | ||
Panford Investment Corp. | Corporate Officer/Principal | ||
EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | Pharmaceuticals: Major | Director/Board Member | |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Biotechnology | Chief Tech/Sci/R&D Officer | |
AVICANNA INC. | Biotechnology | Chairman | |
PURE GLOBAL CANNABIS INC. | Pharmaceuticals: Other | Chairman | |
HBM HOLDINGS LIMITED | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
OncoOne Research & Development GmbH
OncoOne Research & Development GmbH BiotechnologyHealth Technology OncoOne Research & Development GmbH engages in the research in as well as the development, manufacturing, and commercialization of therapeutics, specifically in the field of oncology. It specializes in the development of drugs and novel therapeutics for the treatment of solid tumor cancers. The company was founded by Randolf Kerschbaumer, Michael Thiele, and Alexander Schinagl in June 2018 and is headquartered in Klosterneuburg, Austria. | Biotechnology | Corporate Officer/Principal | |
ATLANTIC COASTAL ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
PANACEA GLOBAL INC | Medical Specialties | Chairman |
Statistieken
Internationaal
Canada | 18 |
Verenigde Staten | 11 |
China | 3 |
Verenigd Koninkrijk | 2 |
Oostenrijk | 2 |
Sectoraal
Health Technology | 16 |
Consumer Services | 8 |
Technology Services | 3 |
Finance | 3 |
Commercial Services | 2 |
Operationeel
Director/Board Member | 14 |
Corporate Officer/Principal | 7 |
Independent Dir/Board Member | 6 |
Chairman | 5 |
Chief Tech/Sci/R&D Officer | 5 |
Sterkste connecties
Insiders | |
---|---|
Chandrakant Panchal | 22 |
Humphrey Gardner | 9 |
Brent Meadows | 4 |
- Beurs
- Insiders
- Jeff Caravella
- Bedrijfsconnecties